From Health Canada:
GlaxoSmithKline Inc. (GSK), in consultation with Health Canada, would like to inform you of recent safety data concerning rosiglitazone-containing products, i.e., AVANDIA® (rosiglitazone maleate) tablets, AVANDAMET® (rosiglitazone maleate/metformin hydrochloride) tablets and AVANDARYLTM (rosiglitazone maleate/glimepiride) tablets. These products are used in treating type 2 diabetes mellitus.
For Health Professionals
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment